Critical Care

official impact factor 4.60

Clinical review: Balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use

Thomas G Slama

Critical Care 2008, 12:233 doi:10.1186/cc6994

Accesses  

  • Last 30 days: 88 accesses
  • Last 365 days: 841 accesses
  • All time: 3761 accesses